Take Your Trading To The Next Level. Get Started Here!

Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs 

July 26, 2024 Comments Off

The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into key drug brands and research and development programs.